Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 399 (LINC00399) is a non-coding RNA transcript located at 13q33.3 in the human genome[1][4][7]. As a member of the lincRNA class, it exceeds 200 nucleotides in length and is transcribed from a region not overlapping with known protein-coding genes[2][5]. lincRNAs are known for roles in chromatin architecture remodeling, transcriptional regulation, and, more generally, fine-tuning gene expression with tissue specificity[2][5]. However, the functional role, disease association, and clinical relevance of LINC00399 itself have not been specifically characterized in the current literature or disease databases. No interacting drugs, biomarker roles, or direct disease associations are reported for this RNA.
Not applicable (no drugs or small molecules known to modulate LINC00399 specifically)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 399 (LINC00399).